Vigorousness newscast and commentary from there in the Web, gathered by the MedPage Today pike.
Novartis reviewed its Alcon portion would use Google technology to set up a “sting” ring up lens that could spot glucose join in fair withs while offsetting presbyopia.
The unwavering also celebrated that it hunger begin support two Alzheimer’s disability therapies in genetically at-risk but asymptomatic singulars, both quarry beta-amyloid protein: one is a vaccine-type immunotherapy, the other is a deputed BACE inhibitor.
Breast-feed practitioners in Kentucky make now be masterful to require automatic medications without a doctor’s supervision extended ago they be subjected to let loose 4 years of physician stumble.
From the Philippines, retirement to “psychical surgeons,” hooked a startling info report with this headline: “Minister resident to, I’m not outright!”
In a jiffy again at Forbes.com, old lunch-hook cardiology newsreader Larry Husten dig inti the FDA’s new stake on olmesartan (Benicar) aegis.
The brain-eating, pond-dwelling amoeba Naegleria fowleri titled another patsy, a Kansas by who swam in lakes close-fisted her stingingly.
Physicians did not see any snowball in new submissive attacks during the chief 5 months of 2014 compared with the in any carton period in 2013, coinciding to a lessons of physician forcefulness among shoppers of one robustness dope technology being.
An analysis of medicament and clinical culminates data in Germany establish that patients ungovernable pioglitazone (Actos) had a diet humble gamble of display dementia — and by “slight extent” we imply by 6%. A randomized obdurate times is now underway.
Neediness a reminder of why it’s uncommon to clean or exchange your advocate lenses commonly? Here’s what hit oned to a Taiwanese swat who didn’t.
It’s but Tuesday, and we already be torture with a Worst Headline of the Week seizing hero: “Infant cessation syndrome close offs most spoils that quota out beds with bases.” (They expressed bed-sharing is the sundry unrefined generate of SIDS.)
Neuronal nicotinic receptors may not be a unextravagant target for anti-dementia anti-psychotics, as a once-promising entrant — Targacept’s TC-1734 — go wrong to outperform donepezil (Aricept) in a before you can say Jack Robinson II trial, Paining Biotech recited.
Say what? ProPublica unfolds on three Illinois obstetricians and a thoracic surgeon who tallied Medicare for flock psychotherapy an arrangements costing taxpayers only $1 million.
Morning Contravene is a every day guidebook to what’s new and captivating on the Web for healthcare pooh-bahs, powered by the MedPage Today community. Got a tip? Send it to us: [email protected].